Newly Diagnosed? Rely on ‘Research and Hope’, Says Doctor Turned Patient With Cancer

Video

Doctor turned patient with cancer, Dr. Dan Tran, discusses how research and new medicine can help your hang onto hope during the cancer journey.

As a health care provider, oral and maxillofacial surgeon Dr. Dan Tran thought receiving a diagnosis of stage 4 lung cancer at the age of 30 would make him a difficult patient. “As a doctor, you also end up being the worst patient,” he said in an interview with CURE®. “You hate treating other doctors, because they just think they know a lot more (and say) ‘Oh, I read that that, too.’”

But his background in the medical field ended up giving him hope about cancer treatment advances; hope that he wants to share with other patients who may have recently received a diagnosis of their own.

“When I was diagnosed with cancer, the chances of me surviving was six to nine months and now, here I still am,” Tran says.

Transcription:

CURE®: What advice would you offer someone who received a cancer diagnosis of their own?

Tran: I think the biggest message I have for patients who have been diagnosed with cancer would be to be hopeful. I mean, I think research and hope are pretty much the two things I think that gets me through it. Just knowing that there's going to be some new treatment out there.

Medicine is moving at such a fast pace right now. We have no idea where we're going to be in five years. When I was diagnosed with cancer, the chances of me surviving was six to nine months and now, here I still am. And so, anybody who's been newly diagnosed, just don't give up hope. Just hang in there. There's a chance that something may be coming out for you, and just don't give up.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.